L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3160
ETF rank
$19.61 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
$14.26
Share price
2.77%
Change (1 day)
45.65%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of April 2026: 0.49%